These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 29168007

  • 1. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
    Mulé S, Pigneur F, Quelever R, Tenenhaus A, Baranes L, Richard P, Tacher V, Herin E, Pasquier H, Ronot M, Rahmouni A, Vilgrain V, Luciani A.
    Eur Radiol; 2018 May; 28(5):1977-1985. PubMed ID: 29168007
    [Abstract] [Full Text] [Related]

  • 2. Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma.
    Gordic S, Puippe GD, Krauss B, Klotz E, Desbiolles L, Lesurtel M, Müllhaupt B, Pfammatter T, Alkadhi H.
    Radiology; 2016 Jul; 280(1):78-87. PubMed ID: 26824712
    [Abstract] [Full Text] [Related]

  • 3. Iodine material density images in dual-energy CT: quantification of contrast uptake and washout in HCC.
    Pfeiffer D, Parakh A, Patino M, Kambadakone A, Rummeny EJ, Sahani DV.
    Abdom Radiol (NY); 2018 Dec; 43(12):3317-3323. PubMed ID: 29774382
    [Abstract] [Full Text] [Related]

  • 4. Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion?
    Stiller W, Skornitzke S, Fritz F, Klauss M, Hansen J, Pahn G, Grenacher L, Kauczor HU.
    Invest Radiol; 2015 Oct; 50(10):703-8. PubMed ID: 26039774
    [Abstract] [Full Text] [Related]

  • 5. Quantitative dual energy CT measurements in rabbit VX2 liver tumors: Comparison to perfusion CT measurements and histopathological findings.
    Zhang LJ, Wu S, Wang M, Lu L, Chen B, Jin L, Wang J, Larson AC, Lu GM.
    Eur J Radiol; 2012 Aug; 81(8):1766-75. PubMed ID: 21835570
    [Abstract] [Full Text] [Related]

  • 6. Can quantitative iodine parameters on DECT replace perfusion CT parameters in colorectal cancers?
    Kang HJ, Kim SH, Bae JS, Jeon SK, Han JK.
    Eur Radiol; 2018 Nov; 28(11):4775-4782. PubMed ID: 29789907
    [Abstract] [Full Text] [Related]

  • 7. Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.
    Thaiss WM, Haberland U, Kaufmann S, Spira D, Thomas C, Nikolaou K, Horger M, Sauter AW.
    Eur Radiol; 2016 Sep; 26(9):2929-36. PubMed ID: 26679179
    [Abstract] [Full Text] [Related]

  • 8. Image quality of mean temporal arterial and mean temporal portal venous phase images calculated from low dose dynamic volume perfusion CT datasets in patients with hepatocellular carcinoma and pancreatic cancer.
    Wang X, Henzler T, Gawlitza J, Diehl S, Wilhelm T, Schoenberg SO, Jin ZY, Xue HD, Smakic A.
    Eur J Radiol; 2016 Nov; 85(11):2104-2110. PubMed ID: 27776665
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C, Thaiss WM, Kärgel R, Grimmer R, Fritz J, Ioanoviciu SD, Ketelsen D, Nikolaou K, Horger M.
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [Abstract] [Full Text] [Related]

  • 10. Dual-energy CT iodine maps as an alternative quantitative imaging biomarker to abdominal CT perfusion: determination of appropriate trigger delays for acquisition using bolus tracking.
    Skornitzke S, Fritz F, Mayer P, Koell M, Hansen J, Pahn G, Hackert T, Kauczor HU, Stiller W.
    Br J Radiol; 2018 May; 91(1085):20170351. PubMed ID: 29446319
    [Abstract] [Full Text] [Related]

  • 11. Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma.
    Ascenti G, Sofia C, Mazziotti S, Silipigni S, D'Angelo T, Pergolizzi S, Scribano E.
    Clin Radiol; 2016 Sep; 71(9):938.e1-9. PubMed ID: 27241866
    [Abstract] [Full Text] [Related]

  • 12. Quantification of variability in breath-hold perfusion CT of hepatocellular carcinoma: a step toward clinical use.
    Petralia G, Summers P, Viotti S, Montefrancesco R, Raimondi S, Bellomi M.
    Radiology; 2012 Nov; 265(2):448-56. PubMed ID: 22996748
    [Abstract] [Full Text] [Related]

  • 13. Prediction of microvascular invasion of hepatocellular carcinoma: value of volumetric iodine quantification using preoperative dual-energy computed tomography.
    Kim TM, Lee JM, Yoon JH, Joo I, Park SJ, Jeon SK, Schmidt B, Martin S.
    Cancer Imaging; 2020 Aug 18; 20(1):60. PubMed ID: 32811570
    [Abstract] [Full Text] [Related]

  • 14. Iodine Parameters in Triple-Bolus Dual-Energy CT Correlate With Perfusion CT Biomarkers of Angiogenesis in Renal Cell Carcinoma.
    Manoharan D, Netaji A, Das CJ, Sharma S.
    AJR Am J Roentgenol; 2020 Apr 18; 214(4):808-816. PubMed ID: 32069083
    [Abstract] [Full Text] [Related]

  • 15. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
    Kaufmann S, Horger T, Oelker A, Kloth C, Nikolaou K, Schulze M, Horger M.
    Eur J Radiol; 2015 Jun 18; 84(6):1029-35. PubMed ID: 25816994
    [Abstract] [Full Text] [Related]

  • 16. Material density iodine images in dual-energy CT: Detection and characterization of hypervascular liver lesions compared to magnetic resonance imaging.
    Muenzel D, Lo GC, Yu HS, Parakh A, Patino M, Kambadakone A, Rummeny EJ, Sahani DV.
    Eur J Radiol; 2017 Oct 18; 95():300-306. PubMed ID: 28987684
    [Abstract] [Full Text] [Related]

  • 17. Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib.
    Dai X, Schlemmer HP, Schmidt B, Höh K, Xu K, Ganten TM, Ganten MK.
    Eur J Radiol; 2013 Feb 18; 82(2):327-34. PubMed ID: 23246016
    [Abstract] [Full Text] [Related]

  • 18. Multidetector CT with double arterial phase and high-iodine-concentration contrast agent in the detection of hepatocellular carcinoma.
    Pozzi Mucelli RM, Como G, Del Frate C, Iuri D, Furlan A, Al-Grhiw E, Bazzocchi M.
    Radiol Med; 2006 Mar 18; 111(2):181-91. PubMed ID: 16671376
    [Abstract] [Full Text] [Related]

  • 19. Dual-energy liver CT: effect of monochromatic imaging on lesion detection, conspicuity, and contrast-to-noise ratio of hypervascular lesions on late arterial phase.
    Shuman WP, Green DE, Busey JM, Mitsumori LM, Choi E, Koprowicz KM, Kanal KM.
    AJR Am J Roentgenol; 2014 Sep 18; 203(3):601-6. PubMed ID: 25148163
    [Abstract] [Full Text] [Related]

  • 20. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.
    Ippolito D, Capraro C, Casiraghi A, Cestari C, Sironi S.
    Eur Radiol; 2012 Apr 18; 22(4):803-11. PubMed ID: 22086560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.